2021 Q4 Form 10-Q Financial Statement
#000121390021061543 Filed on November 23, 2021
Income Statement
| Concept | 2021 Q4 |
|---|---|
| Revenue | $0.00 |
| YoY Change | |
| Cost Of Revenue | |
| YoY Change | |
| Gross Profit | |
| YoY Change | |
| Gross Profit Margin | |
| Selling, General & Admin | $6.220M |
| YoY Change | 626.64% |
| % of Gross Profit | |
| Research & Development | $9.522M |
| YoY Change | 471.55% |
| % of Gross Profit | |
| Depreciation & Amortization | $16.00K |
| YoY Change | -125.0% |
| % of Gross Profit | |
| Operating Expenses | $15.74M |
| YoY Change | 524.19% |
| Operating Profit | |
| YoY Change | |
| Interest Expense | -$91.00K |
| YoY Change | -108.78% |
| % of Operating Profit | |
| Other Income/Expense, Net | -$954.0K |
| YoY Change | 4670.0% |
| Pretax Income | -$16.78M |
| YoY Change | 940.42% |
| Income Tax | $35.00K |
| % Of Pretax Income | |
| Net Earnings | -$16.82M |
| YoY Change | 911.24% |
| Net Earnings / Revenue | |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share | -$13.92M |
| COMMON SHARES | |
| Basic Shares Outstanding | 0.000 shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2021 Q4 |
|---|---|
| SHORT-TERM ASSETS | |
| Cash & Short-Term Investments | $19.61M |
| YoY Change | |
| Cash & Equivalents | $19.56M |
| Short-Term Investments | $53.00K |
| Other Short-Term Assets | $101.0K |
| YoY Change | |
| Inventory | |
| Prepaid Expenses | $36.00K |
| Receivables | |
| Other Receivables | |
| Total Short-Term Assets | $21.05M |
| YoY Change | |
| LONG-TERM ASSETS | |
| Property, Plant & Equipment | $94.00K |
| YoY Change | |
| Goodwill | |
| YoY Change | |
| Intangibles | $28.14M |
| YoY Change | |
| Long-Term Investments | $350.0K |
| YoY Change | |
| Other Assets | |
| YoY Change | |
| Total Long-Term Assets | $28.58M |
| YoY Change | |
| TOTAL ASSETS | |
| Total Short-Term Assets | $21.05M |
| Total Long-Term Assets | $28.58M |
| Total Assets | $49.63M |
| YoY Change | |
| SHORT-TERM LIABILITIES | |
| YoY Change | |
| Accounts Payable | $698.0K |
| YoY Change | |
| Accrued Expenses | $8.688M |
| YoY Change | |
| Deferred Revenue | |
| YoY Change | |
| Short-Term Debt | $0.00 |
| YoY Change | |
| Long-Term Debt Due | |
| YoY Change | |
| Total Short-Term Liabilities | $20.72M |
| YoY Change | |
| LONG-TERM LIABILITIES | |
| Long-Term Debt | $979.0K |
| YoY Change | |
| Other Long-Term Liabilities | $7.190M |
| YoY Change | |
| Total Long-Term Liabilities | $8.169M |
| YoY Change | |
| TOTAL LIABILITIES | |
| Total Short-Term Liabilities | $20.72M |
| Total Long-Term Liabilities | $8.169M |
| Total Liabilities | $30.85M |
| YoY Change | |
| SHAREHOLDERS EQUITY | |
| Retained Earnings | -$66.49M |
| YoY Change | |
| Common Stock | $1.000K |
| YoY Change | |
| Preferred Stock | |
| YoY Change | |
| Treasury Stock (at cost) | |
| YoY Change | |
| Treasury Stock Shares | |
| Shareholders Equity | $18.78M |
| YoY Change | |
| Total Liabilities & Shareholders Equity | $49.63M |
| YoY Change |
Cashflow Statement
| Concept | 2021 Q4 |
|---|---|
| OPERATING ACTIVITIES | |
| Net Income | -$16.82M |
| YoY Change | 911.24% |
| Depreciation, Depletion And Amortization | $16.00K |
| YoY Change | -125.0% |
| Cash From Operating Activities | -$4.483M |
| YoY Change | 83.65% |
| INVESTING ACTIVITIES | |
| Capital Expenditures | $0.00 |
| YoY Change | -100.0% |
| Acquisitions | |
| YoY Change | |
| Other Investing Activities | $0.00 |
| YoY Change | |
| Cash From Investing Activities | $0.00 |
| YoY Change | -100.0% |
| FINANCING ACTIVITIES | |
| Cash Dividend Paid | |
| YoY Change | |
| Common Stock Issuance & Retirement, Net | |
| YoY Change | |
| Debt Paid & Issued, Net | |
| YoY Change | |
| Cash From Financing Activities | 18.44M |
| YoY Change | 582.13% |
| NET CHANGE | |
| Cash From Operating Activities | -4.483M |
| Cash From Investing Activities | 0.000 |
| Cash From Financing Activities | 18.44M |
| Net Change In Cash | 13.96M |
| YoY Change | 5288.03% |
| FREE CASH FLOW | |
| Cash From Operating Activities | -$4.483M |
| Capital Expenditures | $0.00 |
| Free Cash Flow | -$4.483M |
| YoY Change | 83.88% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
USD | ||
| us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
USD | ||
| CY2021Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
USD | |
| CY2020Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
USD | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
USD | ||
| CY2020Q2 | allr |
Stock Issued During Period Value Acquisition Of Nci
StockIssuedDuringPeriodValueAcquisitionOfNCI
|
USD | |
| CY2020Q3 | allr |
Stock Issued During Period Value Acquisition Of Nci
StockIssuedDuringPeriodValueAcquisitionOfNCI
|
USD | |
| CY2021Q2 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
USD | |
| CY2021Q3 | allr |
Units Issued For Share Issuance Costs
UnitsIssuedForShareIssuanceCosts
|
USD | |
| CY2021Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
0 | shares |
| CY2021Q3 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
USD | |
| CY2020Q3 | allr |
Proceed From Sale Of Ip
ProceedFromSaleOfIP
|
USD | |
| allr |
Proceed From Sale Of Ip
ProceedFromSaleOfIP
|
USD | ||
| CY2021Q3 | allr |
Interests Expense
InterestsExpense
|
USD | |
| CY2020Q3 | allr |
Interests Expense
InterestsExpense
|
USD | |
| CY2021Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
USD | |
| CY2020Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
USD | |
| CY2021Q3 | allr |
Change In Fair Value Attributable To Instrument Specific Credit Risk
ChangeInFairValueAttributableToInstrumentSpecificCreditRisk
|
USD | |
| CY2020Q3 | allr |
Change In Fair Value Attributable To Instrument Specific Credit Risk
ChangeInFairValueAttributableToInstrumentSpecificCreditRisk
|
USD | |
| CY2021Q3 | us-gaap |
Grants Receivable Current
GrantsReceivableCurrent
|
USD | |
| CY2020 | allr |
Other Asset
OtherAsset
|
USD | |
| CY2020Q4 | us-gaap |
Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
|
USD | |
| CY2019Q4 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
USD | |
| CY2021Q3 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
USD | |
| CY2020 | allr |
Stock Issued During Period Shares Stock Options Number Exercised
StockIssuedDuringPeriodSharesStockOptionsNumberExercised
|
shares | |
| CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
| CY2021Q3 | allr |
Common Stock Par Value
CommonStockParValue
|
33 | |
| CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | |
| CY2021Q3 | allr |
Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePriceGranted
|
||
| CY2020Q4 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
shares | |
| CY2020Q4 | allr |
Weighted Average Exercise Price Exercised
WeightedAverageExercisePriceExercised
|
||
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
USD | ||
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
USD | ||
| CY2020 | allr |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Issuance Of Investor Warrants Note14a
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisIssuanceOfInvestorWarrantsNote14a
|
USD | |
| allr |
Financing Facility Adjustments Converted To Equity On Settlement
FinancingFacilityAdjustmentsConvertedToEquityOnSettlement
|
USD | ||
| allr |
Fair Value Adjustments To1 Warrants
FairValueAdjustmentsTO1Warrants
|
USD | ||
| CY2020 | allr |
Fair Value Adjustments To3 Warrants
FairValueAdjustmentsTO3Warrants
|
USD | |
| CY2020 | allr |
Fairvalueadjustments Translation Effect
FairvalueadjustmentsTranslationEffect
|
USD | |
| CY2020 | allr |
Exercise Of To2 And To3 Warrants
ExerciseOfTO2AndTO3Warrants
|
USD | |
| CY2021Q3 | allr |
Change In Fair Value Of Convertible Debt
ChangeInFairValueOfConvertibleDebt
|
USD | |
| CY2021Q3 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
USD | |
| us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
USD |
